Monday, May 02, 2005
FDA Approves New Lizard Derived Shot For Diabetes Treatment
The makers of the new drug, Amylin Pharmaceuticals and Eli Lilly & Co., said the lizard shot would begin selling by June 1 for an undisclosed price.
Type 2 diabetics got a new option to help control their blood sugar Friday, a drug derived from the saliva of the Gila monster -- but one that must be injected twice a day. The Food and Drug Administration approved Byetta, known chemically as exenatide, the first in a new class of medications for Type 2 diabetes -- but for now, it's supposed to be used together with older diabetes drugs, not alone.
FDA approves lizard-derived shot as new diabetes treatment - News - MSNBC.com
posted by Unknown
PermaLink @ 9:50 AM